Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.

Tobudic S, Plunger V, Sunder-Plassmann G, Riegersperger M, Burgmann H.

PLoS One. 2012;7(9):e46133. doi: 10.1371/journal.pone.0046133. Epub 2012 Sep 28.

2.

The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.

Goldblatt D, Southern J, Andrews N, Ashton L, Burbidge P, Woodgate S, Pebody R, Miller E.

Clin Infect Dis. 2009 Nov 1;49(9):1318-25. doi: 10.1086/606046.

PMID:
19814624
3.

A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients.

Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, Humar A.

Clin Infect Dis. 2008 Oct 1;47(7):885-92. doi: 10.1086/591537.

PMID:
18715160
4.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
5.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.

O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, Gootenberg JE, Nold JT, Eskenazi A, Snader SJ, Lederman HM.

Pediatrics. 2000 Nov;106(5):965-72.

PMID:
11061761
6.

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, Katlama C, Yéni P, Morineau P, Delfraissy JF, Chêne G, Lévy Y; ANRS 114-Pneumovac Study Group.

AIDS. 2007 Nov 30;21(18):2425-34.

PMID:
18025879
7.
8.

Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial.

Søgaard OS, Lohse N, Harboe ZB, Offersen R, Bukh AR, Davis HL, Schønheyder HC, Østergaard L.

Clin Infect Dis. 2010 Jul 1;51(1):42-50. doi: 10.1086/653112.

PMID:
20504165
9.

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

King JC Jr, Vink PE, Farley JJ, Parks M, Smilie M, Madore D, Lichenstein R, Malinoski F.

Pediatr Infect Dis J. 1996 Mar;15(3):192-6.

PMID:
8852905
10.

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

Choo S, Seymour L, Morris R, Quataert S, Lockhart S, Cartwright K, Finn A.

Pediatr Infect Dis J. 2000 Sep;19(9):854-62.

PMID:
11001109
11.
12.

Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.

Knuf M, Pankow-Culot H, Grunert D, Rapp M, Panzer F, Köllges R, Fanic A, Habib A, Borys D, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2012 Jan;31(1):e31-6. doi: 10.1097/INF.0b013e3182323ac2.

PMID:
21909049
13.

Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial.

Kumar D, Welsh B, Siegal D, Chen MH, Humar A.

Am J Transplant. 2007 Mar;7(3):633-8. Epub 2007 Jan 11.

14.

Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients.

Kumar D, Rotstein C, Miyata G, Arlen D, Humar A.

J Infect Dis. 2003 May 15;187(10):1639-45. Epub 2003 Apr 23.

PMID:
12721944
15.

Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?

Hey C, Rose MA, Kujumdshiev S, Gstoettner W, Schubert R, Zielen S.

Laryngoscope. 2005 Sep;115(9):1586-90.

PMID:
16148699
16.

Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.

Clin Infect Dis. 2007 May 1;44(9):1173-9. Epub 2007 Mar 23.

PMID:
17407035
17.

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.

Peñaranda M, Payeras A, Cambra A, Mila J, Riera M; Majorcan Pneumococcal Study Group.

AIDS. 2010 May 15;24(8):1226-8. doi: 10.1097/QAD.0b013e3283389de5.

PMID:
20299956
18.

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

Crum-Cianflone NF, Huppler Hullsiek K, Roediger M, Ganesan A, Patel S, Landrum ML, Weintrob A, Agan BK, Medina S, Rahkola J, Hale BR, Janoff EN; Infectious Disease Clinical Research Program HIV Working Group.

J Infect Dis. 2010 Oct 1;202(7):1114-25. doi: 10.1086/656147.

19.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S66-76. doi: 10.1097/INF.0b013e318199f8ef.

PMID:
19325449
20.

Supplemental Content

Support Center